NDC 0002-4103 – Mounjaro
Tirzepatide 8.33 mg/mL · Injection, Solution · Subcutaneous
Product NDC0002-4103
Product details
- Brand name
- Mounjaro
- Generic name
- tirzepatide
- Labeler
- Eli Lilly and Company
- Dosage form
- Injection, Solution
- Route
- Subcutaneous
- Marketing category
- NDA · NDA215866
- Marketed since
- January 7, 2026
- Listing expires
- December 31, 2027
- Pharmacologic class
- GLP-1 Receptor Agonist; Glucose-dependent Insulinotropic Polypeptide Receptor Agonist
Active ingredients
- Tirzepatide 8.33 mg/mL
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 0002-4103-11 | 1 VIAL, MULTI-DOSE in 1 CARTON (0002-4103-11) / 2.4 mL in 1 VIAL, MULTI-DOSE (0002-4103-01) | Jan 7, 2026 |
Other Mounjaro products
- 50090-8024 Tirzepatide 5 mg/.5mL · Injection, Solution · A-S Medication Solutions
- 50090-8025 Tirzepatide 2.5 mg/.5mL · Injection, Solution · A-S Medication Solutions
- 50090-8023 Tirzepatide 7.5 mg/.5mL · Injection, Solution · A-S Medication Solutions
- 50090-8026 Tirzepatide 15 mg/.5mL · Injection, Solution · A-S Medication Solutions
- 50090-8022 Tirzepatide 12.5 mg/.5mL · Injection, Solution · A-S Medication Solutions
- 50090-8021 Tirzepatide 10 mg/.5mL · Injection, Solution · A-S Medication Solutions
- 0002-1243 Tirzepatide 5 mg/.5mL · Injection, Solution · Eli Lilly and Company
- 0002-1457 Tirzepatide 15 mg/.5mL · Injection, Solution · Eli Lilly and Company
- 0002-1471 Tirzepatide 10 mg/.5mL · Injection, Solution · Eli Lilly and Company
- 0002-1484 Tirzepatide 7.5 mg/.5mL · Injection, Solution · Eli Lilly and Company
- 0002-1506 Tirzepatide 2.5 mg/.5mL · Injection, Solution · Eli Lilly and Company
- 0002-2423 Tirzepatide 12.5 mg/.5mL · Injection, Solution · Eli Lilly and Company